Krystal Biotech, Inc. (KRYS) SEC filings
KRYS SEC filings moved a median of +0.23% by the close. KRYS SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the KRYS overview →
54 measured KRYS SEC filing events.
Where these KRYS SEC filings landedvs 54 measured KRYS SEC filing reactions
| Middle 50% of KRYS SEC filing reactions | -2.41% to +3.84% |
|---|---|
| Median reaction (to close) | +0.23% |
| Measured reactions | 54 |
Point-in-time · zero look-ahead
Half of the 54 KRYS SEC filing events with a measured close landed between -2.41% and +3.84%; 56% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Krystal Biotech, Inc. For: Oct 15 | SEC filing · Form 8-K | +0.51% | -0.90% | |
| Form 10-Q Krystal Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.51% | -2.54% | |
| Form 8-K Krystal Biotech, Inc. For: Aug 03 | SEC filing · Form 8-K | +0.51% | -2.54% | |
| Form 8-K Krystal Biotech, Inc. For: Jul 21 | SEC filing · Form 8-K | +0.48% | -0.15% | |
| Form 8-K Krystal Biotech, Inc. For: May 15 | SEC filing · Form 8-K | +0.47% | +1.67% | |
| Form 10-Q Krystal Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | -2.78% | +8.04% | |
| Form 8-K Krystal Biotech, Inc. For: May 04 | SEC filing · Form 8-K | -2.78% | +8.04% | |
| Form ARS Krystal Biotech, Inc. For: Dec 31 | SEC filing · Form ARS | +0.66% | +0.33% | |
| Form DEF 14A Krystal Biotech, Inc. For: Apr 03 | SEC filing · Form DEF | +0.66% | +0.33% | |
| Form DEFA14A Krystal Biotech, Inc. | SEC filing · Form DEFA14A | +0.66% | +0.33% | |
| Form 10-K Krystal Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.35% | -0.40% | |
| Form 8-K Krystal Biotech, Inc. For: Feb 17 | SEC filing · Form 8-K | +0.35% | -0.40% | |
| Form 8-K Krystal Biotech, Inc. For: Jan 11 | SEC filing · Form 8-K | -0.55% | +4.41% | |
| Form 8-K Krystal Biotech, Inc. For: Jan 08 | SEC filing · Form 8-K | -0.20% | +2.71% | |
| Form 8-K Krystal Biotech, Inc. For: Dec 23 | SEC filing · Form 8-K | -0.34% | -0.94% | |
| Form 10-Q Krystal Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.70% | +0.27% | |
| Form 8-K Krystal Biotech, Inc. For: Nov 03 | SEC filing · Form 8-K | -1.70% | +0.27% | |
| Form 8-K Krystal Biotech, Inc. For: Oct 22 | SEC filing · Form 8-K | +0.00% | -2.23% | |
| Form 10-Q Krystal Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | -9.63% | -12.26% | |
| Form 8-K Krystal Biotech, Inc. For: Aug 04 | SEC filing · Form 8-K | -9.63% | -12.26% | |
| Form 8-K Krystal Biotech, Inc. For: Jul 25 | SEC filing · Form 8-K | +0.16% | -1.88% | |
| Form 8-K Krystal Biotech, Inc. For: Jul 24 | SEC filing · Form 8-K | +0.16% | -1.88% | |
| Form 8-K Krystal Biotech, Inc. For: Jul 09 | SEC filing · Form 8-K | +2.84% | +3.91% | |
| Form 8-K Krystal Biotech, Inc. For: Jun 02 | SEC filing · Form 8-K | -1.08% | +4.43% | |
| Form 8-K Krystal Biotech, Inc. For: May 19 | SEC filing · Form 8-K | -0.55% | -0.54% | |
| Form 8-K Krystal Biotech, Inc. For: May 12 | SEC filing · Form 8-K | -1.36% | -3.06% | |
| Form 10-Q Krystal Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.16% | -2.48% | |
| Form 8-K Krystal Biotech, Inc. For: May 05 | SEC filing · Form 8-K | -1.16% | -2.48% | |
| Form 8-K Krystal Biotech, Inc. For: May 06 | SEC filing · Form 8-K | -1.16% | -2.48% | |
| Form 8-K Krystal Biotech, Inc. For: Apr 28 | SEC filing · Form 8-K | -0.78% | +0.14% | |
| Form ARS Krystal Biotech, Inc. For: Dec 31 | SEC filing · Form ARS | +0.89% | +0.23% | |
| Form DEF 14A Krystal Biotech, Inc. For: Apr 03 | SEC filing · Form DEF | +0.89% | +0.23% | |
| Form DEFA14A Krystal Biotech, Inc. | SEC filing · Form DEFA14A | +0.89% | +0.23% | |
| Form 8-K Krystal Biotech, Inc. For: Feb 28 | SEC filing · Form 8-K | -1.17% | -4.07% | |
| Form 10-K Krystal Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | +5.67% | +17.53% | |
| Form 8-K Krystal Biotech, Inc. For: Feb 19 | SEC filing · Form 8-K | +5.67% | +17.53% | |
| Form 8-K Krystal Biotech, Inc. For: Dec 18 | SEC filing · Form 8-K | -5.87% | -11.30% | |
| Form 8-K Krystal Biotech, Inc. For: Dec 12 | SEC filing · Form 8-K | +0.11% | -9.29% | |
| Form 10-Q Krystal Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.04% | +3.64% | |
| Form 8-K Krystal Biotech, Inc. For: Nov 04 | SEC filing · Form 8-K | +0.04% | +3.64% | |
| Form 8-K Krystal Biotech, Inc. For: Aug 28 | SEC filing · Form 8-K | -0.46% | -5.04% | |
| Form 10-Q Krystal Biotech, Inc. For: Jun 30 | SEC filing · Form 10-Q | +3.15% | +9.65% | |
| Form 8-K Krystal Biotech, Inc. For: Aug 05 | SEC filing · Form 8-K | +3.15% | +9.65% | |
| Form 8-K Krystal Biotech, Inc. For: May 21 | SEC filing · Form 8-K | +0.73% | +1.41% | |
| Form 8-K Krystal Biotech, Inc. For: May 07 | SEC filing · Form 8-K | -0.69% | -1.49% | |
| Form 10-Q Krystal Biotech, Inc. For: Mar 31 | SEC filing · Form 10-Q | +3.11% | +7.86% | |
| Form 8-K Krystal Biotech, Inc. For: May 06 | SEC filing · Form 8-K | +3.11% | +7.86% | |
| Form DEF 14A Krystal Biotech, Inc. For: Apr 04 | SEC filing · Form DEF | -0.26% | +1.04% | |
| Form DEFA14A Krystal Biotech, Inc. | SEC filing · Form DEFA14A | -0.26% | +1.04% | |
| Form 10-K Krystal Biotech, Inc. For: Dec 31 | SEC filing · Form 10-K | +4.11% | +23.85% | |
| Form 8-K Krystal Biotech, Inc. For: Feb 26 | SEC filing · Form 8-K | +4.11% | +23.85% | |
| Form S-8 Krystal Biotech, Inc. | SEC filing · Form S-8 | +4.11% | +23.85% | |
| Form 10-Q Krystal Biotech, Inc. For: Sep 30 | SEC filing · Form 10-Q | -7.53% | -7.35% | |
| Form 8-K Krystal Biotech, Inc. For: Nov 06 | SEC filing · Form 8-K | -7.53% | -7.35% |
Keep exploring
More KRYS: earnings → · analyst actions → · KRYS overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | 251 | -0.05% | 50% |
| DOVA PHARMACEUTICALS (DOVA) | 251 | -0.10% | 46% |
| Mersana Therapeutics, Inc. (MRSN) | 251 | -0.20% | 46% |
| Soligenix, Inc. (SNGX) | 251 | -0.71% | 35% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.